Jazz Pharmaceuticals (JAZZ) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Jazz Pharmaceuticals | 15.75 Bn | 13.91 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.02% |
| Dec 31, 2025 | -19.06% |
| Sep 30, 2025 | 135.00% |
| Jun 30, 2025 | -677.47% |
| Mar 31, 2025 | -148.34% |
| Dec 31, 2024 | -11.23% |
| Sep 30, 2024 | 27.70% |
| Jun 30, 2024 | 1,252.85% |
| Mar 31, 2024 | -115.46% |
| Dec 31, 2023 | -35.50% |
| Sep 30, 2023 | 38.30% |
| Jun 30, 2023 | 50.63% |
| Mar 31, 2023 | 129.35% |
| Dec 31, 2022 | -1,300.76% |
| Sep 30, 2022 | -146.16% |
| Jun 30, 2022 | 541.11% |
| Mar 31, 2022 | 117.89% |
| Dec 31, 2021 | 34.67% |
| Sep 30, 2021 | 86.42% |
| Jun 30, 2021 | -409.86% |